Business Standard

Tata Motors moving in the fast lane

Recovery in JLR sales, market share gains in India business and new launches point to good volume outlook

- RAM PRASAD SAHU

Tata Motors’ prospects are on an upward trend and this could help mark a reversal in the underperfo­rmance of its stock, which has not only lagged its listed peers such as Maruti and Mahindra & Mahindra (M&M), but also the broader S&P BSE Sensex in the past one year.

The improvemen­t in prospects is visible in the recovery in Jaguar Land Rover (JLR) sales as well as market share gains in the domestic medium and heavy commercial vehicles (M&HCVs) and passenger vehicles segments. JLR, the UK-based subsidiary of the company, reported a 10 per cent gain in retail volumes after five months of lowerthan-expected sales, due to higher volumes for the new Discovery and Range Rover Velar models.

While sales for JLR in the fiscal year-to-date have been 4.5 per cent, most analysts peg the FY18 sales number closer to the 10 per cent-mark on the back of three new sports utility vehicle models — Velar, Discovery and E-Pace. Analysts at Macquarie expect margins to rise on the back of improving product mix, higher volumes and rolling off of unfavourab­le forex hedges. The Tata Motors’ management has guided for a medium-term margin target of 8-10 per cent at the profit before interest and tax level for JLR.

The improvemen­t in the domestic operations, led by commercial vehicle (CV) volumes, is another trigger. In line with its intention of gaining 500-basis point (bp) market share in FY18 in CVs, Tata Motors has been aggressive­ly rolling out new products. This is gaining traction, especially in the heavy truck segment which is witnessing high demand. The company reported a 72 per cent growth yearon-year (y-o-y) in CV sales on the back of increasing acceptance of Tata Motors’ selective catalytic technology, infrastruc­ture developmen­t led by government funding and restrictio­ns on overloadin­g by truck operators. The company indicated that production ramp-up of the new range of BS-IV vehicles and launches such as the Xenon Yodha pickup have also helped boost sales growth and resulted in market share gains.

After bottoming out at 49.7 per cent in September 2017, the lowest M&HCV market share in the past five months, Tata Motors has increased its share in October and November. Its share currently stands at 54.7 per cent. Its market share yearto-date has crossed 50 per cent and now stands at 50.5 per cent. Even in the overall CV space, Tata Motors has increased its market share by 400 bps from September levels to 48.9 per cent.

Analysts at Nomura say there are further upsides to the 10-15 per cent industry growth estimates for the next two fiscal years, given the government’s focus on doubling spend on building roads over FY18-20 as compared to FY1517. Strong double-digit growth in CVs will benefit Tata Motors, which has filled in the product gaps in its portfolio, especially in the more profitable higher end of the heavy duty truck market.

The company’s passenger vehicles segment, too, recorded a strong 35 per cent y-o-y increase in sales volume as demand for the newly launched compact crossover, Nexon, remains strong. In fact, new vehicle launches have helped the company edge past M&M as the third largest passenger vehicles company in domestic volumes. Analysts expect the growth trend to continue for the rest of the fiscal year for Tata Motors, which has posted a 15 per cent growth in passenger vehicles for the first eight months of FY18.

While brokerages agree that the company’s strategy of regaining its lost market share — especially in CVs — is the right one, it could have some bearing on profitabil­ity. Analysts at Morgan Stanley say the market share focus could keep margins muted and losses would continue for the standalone operations. The company, however, hopes to hit break-even for its Indian operations at the profit before tax level in FY18. If it does, expect Street sentiment to get a boost. Going into FY19, too, volumes for both the India business and JLR are expected to remain healthy, led by existing products as well as those in the pipeline. At the current price, the stock is trading at a reasonable eight times its FY19 estimates, with JLR accounting for 90 per cent of the stock’s value.

 ??  ??
 ??  ??

Newspapers in English

Newspapers from India